COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-
converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for …
converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
CK Tan, YJ Wong, LM Wang, TL Ang… - Journal of …, 2021 - journal-of-hepatology.eu
The COVID-19 pandemic is still raging across the world and vaccination is expected to lead
us out of this pandemic. Although the efficacy of the vaccines is beyond doubt, as many …
us out of this pandemic. Although the efficacy of the vaccines is beyond doubt, as many …
Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis
Background Immunosuppression and comorbidities increase the risk of severe coronavirus
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …
[HTML][HTML] COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
P Li, Y Liu, Z Cheng, X Yu, Y Li - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
[HTML][HTML] Involvement of the liver in COVID-19: A systematic review
JC Kariyawasam, U Jayarajah… - The American journal …, 2022 - ncbi.nlm.nih.gov
COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …
the February 4, 2022. In this review, we have outlined the important liver manifestations of …
Prognosis of French COVID-19 patients with chronic liver disease: a national retrospective cohort study for 2020
V Mallet, N Beeker, S Bouam, P Sogni, S Pol… - Journal of …, 2021 - Elsevier
Background & Aims The impact of chronic liver disease on outcomes in patients with COVID-
19 is uncertain. Hence, we aimed to explore this association. Methods We explored the …
19 is uncertain. Hence, we aimed to explore this association. Methods We explored the …
Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study
J Chen, Y Liu, J Qin, C Ruan, X Zeng… - Postgraduate …, 2022 - academic.oup.com
Purpose of the study Hypertension is one of the most common comorbidities in COVID-19
pneumonia. However, whether it is an independent factor on the severity and mortality of …
pneumonia. However, whether it is an independent factor on the severity and mortality of …